Read + Share
Plaz Torres MC, Jaffe A, Perry R, Marabotto E, et al. Reply: novel antidiabetic drugs and the risk for hepatocellular carcinoma. What
else to expect from these "wonderful" drug classes? Hepatology 2023 Feb 3. doi: 10.1097/HEP.0000000000000312.
PMID: 36724446
|
 |
|
